These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 804436

  • 1. Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.
    Meyer TJ, Azuma I, Ribi EE.
    Immunology; 1975 Feb; 28(2):219-29. PubMed ID: 804436
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I, Kanetsuna F, Taniyama T, Yamamura Y, Hori M.
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [Abstract] [Full Text] [Related]

  • 3. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G, Hiu IJ, Halle-Pannenko O, Bourut C.
    Isr J Med Sci; 1976 Mar; 12(4-5):468-71. PubMed ID: 820673
    [Abstract] [Full Text] [Related]

  • 4. Mycobacterial adjuvant. I. Purification of an adjuvant-active component from wax D(H 37 Ra strain) by preparative thin-layer chromatography.
    Kumazawa Y, Tsushida A, Mizunoe K, Suzuki T, Kawanishi Y.
    Jpn J Microbiol; 1972 Jan; 16(1):73-5. PubMed ID: 4625075
    [No Abstract] [Full Text] [Related]

  • 5. [The protective activity of mycobacterial antigens. 3. Protective activity of killed mycobacterial bodies].
    Stavri D, Anagnoste V, Drăghici D.
    Arch Roum Pathol Exp Microbiol; 1970 Jan; 29(1):91-101. PubMed ID: 4936247
    [No Abstract] [Full Text] [Related]

  • 6. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis.
    Ribi E, Meyer TJ, Azuma I, Parker R, Brehmer W.
    Cell Immunol; 1975 Mar; 16(1):1-10. PubMed ID: 803876
    [No Abstract] [Full Text] [Related]

  • 7. Chemical structure of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG.
    Petit JF, Wietzerbin J, Das BC, Lederer E.
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):118-25. PubMed ID: 126548
    [Abstract] [Full Text] [Related]

  • 8. Induction of allergic encephalomyelitis using hydrosoluble mycobacterial fractions.
    Westall FC, Thompson M, Migliore-Samour D, Jollés P.
    Eur J Immunol; 1976 Jul; 5(7):504-5. PubMed ID: 61873
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy of guinea pig cancer with BCG.
    Zbar B.
    Johns Hopkins Med J Suppl; 1974 Jul; 3():121-30. PubMed ID: 4608693
    [No Abstract] [Full Text] [Related]

  • 10. Adjuvant-polyarthritogenicity of cell walls of mycobacteria, nocardia and corynebacteria.
    Azuma I, Kanetsuna F, Kada Y, Takashima T, Yamamura Y.
    Jpn J Microbiol; 1972 Jul; 16(4):333-6. PubMed ID: 4631613
    [No Abstract] [Full Text] [Related]

  • 11. Enhancement of resistance of mice to tuberculosis by purified components of mycobacterial lipid fractions.
    Anacker RL, Matsumoto J, Ribi E, Smith RF, Yamamoto K.
    J Infect Dis; 1973 Apr; 127(4):357-64. PubMed ID: 4632876
    [No Abstract] [Full Text] [Related]

  • 12. Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria.
    Kotani S, Narita T, Stewart-Tull DE, Shimono T, Watanabe Y.
    Biken J; 1975 Jun; 18(2):77-92. PubMed ID: 1180872
    [Abstract] [Full Text] [Related]

  • 13. Studies on the composition of adjuvants which selectively enhance delayed-type hypersensitivity to lipid conjugated protein antigens.
    Champlin R, Hunter RL.
    J Immunol; 1975 Jan; 114(1 Pt 1):76-80. PubMed ID: 1089714
    [Abstract] [Full Text] [Related]

  • 14. Comparison of chemical and biological properties of water-soluble adjuvants prepared from Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium smegmatis.
    Kumazawa Y, Shibusawa A, Nakagawa N, Kojima Y, Mizunoe K.
    Kitasato Arch Exp Med; 1976 Dec; 49(4):153-62. PubMed ID: 829910
    [No Abstract] [Full Text] [Related]

  • 15. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I, Yamamura Y.
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract] [Full Text] [Related]

  • 16. Adjuvanticity and strains of mycobacteria.
    Hiu IJ.
    Jpn J Exp Med; 1980 Jun; 50(3):183-8. PubMed ID: 7001095
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the mode of immunopotentiating action of BCG and wax D. I. Effect on the immune response to SRBC.
    Ishibashi T, Harada Y, Yamada H, Harada S, Takamoto M.
    Jpn J Exp Med; 1977 Jun; 47(3):163-8. PubMed ID: 410972
    [Abstract] [Full Text] [Related]

  • 18. [Chemistry and biological activities of the components of Mycobacterium tuberculosis].
    Azuma I, Yamamura Y.
    Kekkaku; 1975 Dec; 50(11):429-40. PubMed ID: 815693
    [No Abstract] [Full Text] [Related]

  • 19. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE, Meyer TJ, Azuma I, Zbar B.
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract] [Full Text] [Related]

  • 20. Peptidoglycan adjuvants: minimal structure required for activity.
    Adam A, Ellouz F, Ciorbaru R, Petit JF, Lederer E.
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):341-8. PubMed ID: 126566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.